195 related articles for article (PubMed ID: 38085286)
1. Value of CT quantification in progressive fibrosing interstitial lung disease: a deep learning approach.
Koh SY; Lee JH; Park H; Goo JM
Eur Radiol; 2023 Dec; ():. PubMed ID: 38085286
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
[TBL] [Abstract][Full Text] [Related]
3. Deep Learning-based Fibrosis Extent on Computed Tomography Predicts Outcome of Fibrosing Interstitial Lung Disease Independent of Visually Assessed Computed Tomography Pattern.
Oh AS; Lynch DA; Swigris JJ; Baraghoshi D; Dyer DS; Hale VA; Koelsch TL; Marrocchio C; Parker KN; Teague SD; Flaherty KR; Humphries SM
Ann Am Thorac Soc; 2024 Feb; 21(2):218-227. PubMed ID: 37696027
[No Abstract] [Full Text] [Related]
4. Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases.
Mononen M; Saari E; Hasala H; Kettunen HP; Suoranta S; Nurmi H; Kärkkäinen M; Selander T; Randell J; Laurikka J; Uibu T; Koskela H; Kaarteenaho R; Purokivi M
BMC Pulm Med; 2022 Aug; 22(1):313. PubMed ID: 35965320
[TBL] [Abstract][Full Text] [Related]
5. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
[TBL] [Abstract][Full Text] [Related]
6. Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.
Ahn Y; Lee SM; Choi S; Lee JS; Choe J; Do KH; Seo JB
Eur Radiol; 2023 Nov; 33(11):8251-8262. PubMed ID: 37266656
[TBL] [Abstract][Full Text] [Related]
7. CT predictors of outcomes in patients with connective tissue disease and progressive lung fibrosis.
Shou AY; Salvatore MM
Clin Imaging; 2023 Feb; 94():42-49. PubMed ID: 36493681
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung disease.
Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ;
Respirology; 2022 Oct; 27(10):854-862. PubMed ID: 35652240
[TBL] [Abstract][Full Text] [Related]
9. Serial automated quantitative CT analysis in idiopathic pulmonary fibrosis: functional correlations and comparison with changes in visual CT scores.
Jacob J; Bartholmai BJ; Rajagopalan S; Kokosi M; Egashira R; Brun AL; Nair A; Walsh SLF; Karwoski R; Wells AU
Eur Radiol; 2018 Mar; 28(3):1318-1327. PubMed ID: 28963678
[TBL] [Abstract][Full Text] [Related]
10. Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis.
Bowman WS; Newton CA; Linderholm AL; Neely ML; Pugashetti JV; Kaul B; Vo V; Echt GA; Leon W; Shah RJ; Huang Y; Garcia CK; Wolters PJ; Oldham JM
Lancet Respir Med; 2022 Jun; 10(6):593-602. PubMed ID: 35063079
[TBL] [Abstract][Full Text] [Related]
11. Progressive fibrosing interstitial lung disease: prevalence and clinical outcome.
Kwon BS; Choe J; Chae EJ; Hwang HS; Kim YG; Song JW
Respir Res; 2021 Oct; 22(1):282. PubMed ID: 34719401
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of deep learning-based fibrosis quantification on chest CT in idiopathic pulmonary fibrosis.
Nam JG; Choi Y; Lee SM; Yoon SH; Goo JM; Kim H
Eur Radiol; 2023 May; 33(5):3144-3155. PubMed ID: 36928568
[TBL] [Abstract][Full Text] [Related]
13. Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease.
Nawata T; Shirai Y; Suzuki M; Kuwana M
Rheumatology (Oxford); 2021 Jan; 60(1):250-255. PubMed ID: 32699895
[TBL] [Abstract][Full Text] [Related]
14. Deep Learning-Based CT Reconstruction Kernel Conversion in the Quantification of Interstitial Lung Disease: Effect on Reproducibility.
Ahn Y; Lee SM; Nam Y; Lee H; Choe J; Do KH; Seo JB
Acad Radiol; 2024 Feb; 31(2):693-705. PubMed ID: 37516583
[TBL] [Abstract][Full Text] [Related]
15. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A
Respiration; 2020; 99(10):838-845. PubMed ID: 33264777
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
17. Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study.
Sebastiani M; Venerito V; Laurino E; Gentileschi S; Atzeni F; Canofari C; Andrisani D; Cassone G; Lavista M; D'Alessandro F; Vacchi C; Scardapane A; Frediani B; Cazzato M; Salvarani C; Iannone F; Manfredi A
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002655
[TBL] [Abstract][Full Text] [Related]
18. Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study).
Nasser M; Larrieu S; Si-Mohamed S; Ahmad K; Boussel L; Brevet M; Chalabreysse L; Fabre C; Marque S; Revel D; Thivolet-Bejui F; Traclet J; Zeghmar S; Maucort-Boulch D; Cottin V
Eur Respir J; 2021 Feb; 57(2):. PubMed ID: 32943410
[TBL] [Abstract][Full Text] [Related]
19. Real-life prevalence of progressive fibrosing interstitial lung diseases.
Gagliardi M; Berg DV; Heylen CE; Koenig S; Hoton D; Tamirou F; Pieters T; Ghaye B; Froidure A
Sci Rep; 2021 Dec; 11(1):23988. PubMed ID: 34907290
[TBL] [Abstract][Full Text] [Related]
20. Generative Adversarial Network-Based Image Conversion Among Different Computed Tomography Protocols and Vendors: Effects on Accuracy and Variability in Quantifying Regional Disease Patterns of Interstitial Lung Disease.
Hwang HJ; Kim H; Seo JB; Ye JC; Oh G; Lee SM; Jang R; Yun J; Kim N; Park HJ; Lee HY; Yoon SH; Shin KE; Lee JW; Kwon W; Sun JS; You S; Chung MH; Gil BM; Lim JK; Lee Y; Hong SJ; Choi YW
Korean J Radiol; 2023 Aug; 24(8):807-820. PubMed ID: 37500581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]